CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Circulating Plasma Biomarkers for TSU-68, an Oral Antiangiogenic Agent, in Patients with Metastatic Breast Cancer
Changhoon Yoo, Sung-Bae Kim, Jungsil Ro, Seock-Ah Im, Young-Hyuck Im, Jee Hyun Kim, Jin-Hee Ahn, Kyung Hae Jung, Hong Suk Song, Seok Yun Kang, Hee Sook Park, Hyun-Cheol Chung
Cancer Research and Treatment. 2016;48(2):499-507.   Published online 2015 July 14    DOI: https://doi.org/10.4143/crt.2015.089

Excel Download

Circulating Plasma Biomarkers for TSU-68, an Oral Antiangiogenic Agent, in Patients with Metastatic Breast Cancer
Cancer Research and Treatment. 2016;48(2):499-507   Crossref logo
Link1 Link2 Link3

Quality of life on TSU-68: Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline
Asia-Pacific Journal of Clinical Oncology. 2017;13(6):365-371   Crossref logo
Link1 Link2

56PD Quality of life in TSU-68 study: Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline
Annals of Oncology. 2015;26:ix16   Crossref logo
Link1 Link2

5058 POSTER Randomized Phase II Multicenter Trial of Oral Antiangiogenic Agent TSU-68 in Combination With Docetaxel Versus Docetaxel Alone in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline
European Journal of Cancer. 2011;47:S347   Crossref logo
Link1 Link2

Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline: Randomized phase II multicenter trial
Investigational New Drugs. 2014;32(4):753-761   Crossref logo
Link1 Link2 Link3

A multicenter phase II study of TSU-68, an oral multiple tyrosine kinase inhibitor, in combination with docetaxel in metastatic breast cancer patients with anthracycline resistance
Breast Cancer. 2012;21(1):20-27   Crossref logo
Link1 Link2 Link3

Quantification of Cell-Free HER-2 DNA in Plasma from Breast Cancer Patients: Sensitivity for Detection of Metastatic Recurrence and Gene Amplification
Journal of Circulating Biomarkers. 2015;4:9   Crossref logo
Link1 Link2 Link3

Antiangiogenic Therapy in Patients With HER2-Positive Metastatic Breast Cancer: A Case Series
Clinical Breast Cancer. 2014;14(3):e89-e94   Crossref logo
Link1 Link2

Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer
Breast Cancer Research. 2010;12(6):   Crossref logo
Link1 Link2 Link3

Circulating tumor cells and novel biomarkers for prognostic and biological of breast cancer
Breast Cancer Research. 2005;7(S1):   Crossref logo
Link1 Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.